Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
40
RAPT Quote, Financials, Valuation and Earnings
Last price:
$10.31
Seasonality move
:
-6.61%
Day range:
$10.26 - $10.95
52-week range:
$5.67 - $30.08
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
34.39x
P/B ratio:
0.98x
Volume:
102.1K
Avg. volume:
117.4K
1-year change:
-64.93%
Market cap:
$174M
Revenue:
--
EPS (TTM):
-$19.20
Earnings Data
Next earnings date for RAPT
Aug 08
2025
Most recent earnings per share
-$0.64
Beat by $0.45
(May 8/2025)
Consensus Estimate
-$1.09
(May 8/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
RAPT Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | -- | -- | -- | -$0.78 | -- |
| 08/08/2025 | Q2 | -- | -- | -- | -$0.64 | -- |
| 05/08/2025 | Q1 | -- | -- | -$0.64 | -$1.09 | $0.45 |
| 03/06/2025 | Q4 | -- | -- | -$9.12 | -$2.84 | -$6.28 |
| 11/12/2024 | Q3 | -- | -- | -$3.76 | -$4.77 | $1.01 |
| 08/08/2024 | Q2 | -- | -- | -$5.68 | -$5.78 | $0.10 |
| 05/09/2024 | Q1 | -- | -- | -$6.32 | -$6.49 | $0.17 |
| 03/07/2024 | Q4 | -- | -- | -$6.48 | -$6.93 | $0.45 |
| 11/13/2023 | Q3 | -- | -- | -$6.56 | -$6.01 | -$0.55 |
| 08/11/2023 | Q2 | -- | -- | -$5.28 | -$6.26 | $0.98 |
| 05/11/2023 | Q1 | -- | -- | -$6.08 | -$5.36 | -$0.72 |
| 03/14/2023 | Q4 | -- | -- | -$5.12 | -- | -- |
| 11/10/2022 | Q3 | -- | -- | -$5.04 | -- | -- |
| 08/11/2022 | Q2 | -- | $886K | -$4.96 | -- | -- |
| 05/11/2022 | Q1 | -- | $641K | -$5.52 | -- | -- |
| 03/10/2022 | Q4 | -- | $756K | -$4.88 | -- | -- |
| 11/10/2021 | Q3 | -- | $966K | -$5.04 | -- | -- |
| 08/11/2021 | Q2 | -- | $869K | -$5.04 | -- | -- |
| 05/11/2021 | Q1 | -- | $1.2M | -$5.28 | -- | -- |
| 03/30/2021 | Q4 | -- | $1.3M | -$4.16 | -- | -- |
| 11/16/2020 | Q3 | -- | $1.5M | -$4.80 | -- | -- |
| 08/13/2020 | Q2 | -- | $1.3M | -$4.08 | -- | -- |
| 05/14/2020 | Q1 | -- | $935K | -$4.48 | -- | -- |
| 03/30/2020 | Q4 | -- | -- | -$6.96 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$99.28 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$3.74 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$4.24 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$4.35 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$4.75 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$3.75 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$3.83 | -- | -- |
RAPT Therapeutics Earnings Questions
-
How Much did RAPT Therapeutics Generate in Revenue Last Quarter?
RAPT Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did RAPT Therapeutics Beat Earnings Last Quarter?
RAPT Therapeutics announced earnings per share of -$0.64 which represents a beat of analyst forecast a -$1.09 per share.
-
Is RAPT Therapeutics Profitable?
RAPT Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for RAPT Therapeutics EPS Next Year?
RAPT Therapeutics's earnings are forecast to decrease from -$25.52 per share to -$15.18 per share next year representing a decrease of -89.06%.
-
When is RAPT Therapeutics's Earnings Date?
RAPT Therapeutics's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
